>>Description of the research protocol "10085 : Male Breast"

Clinical and Biological Characterization of Male Breast Cancer: an International EORTC, BIG, TBCRC and NABCG Intergroup Study.
Status : Ongoing (but closed to recruitment)

Additional details

Indication (or studied pathology) : Cancer du sein Adjuvant
Brugmann identifier : 10085 : Male Breast
EudraCT identifier : B079201422925
ClinicalTrials.gov identifier : NCT01101425


Involved department : Hemato-oncology
Principal investigator : Efira
Sponsor : EORTC
Contact : Clinical Research Unit

>This protocol was approved by the Bordet ethics committee.